These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23338946)

  • 1. G-Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1.
    Richter GH; Fasan A; Hauer K; Grunewald TG; Berns C; Rössler S; Naumann I; Staege MS; Fulda S; Esposito I; Burdach S
    J Pathol; 2013 May; 230(1):70-81. PubMed ID: 23338946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma.
    von Heyking K; Roth L; Ertl M; Schmidt O; Calzada-Wack J; Neff F; Lawlor ER; Burdach S; Richter GH
    Oncotarget; 2016 Jul; 7(27):41767-41780. PubMed ID: 27363011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
    Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
    J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DKK2 mediates osteolysis, invasiveness, and metastatic spread in Ewing sarcoma.
    Hauer K; Calzada-Wack J; Steiger K; Grunewald TG; Baumhoer D; Plehm S; Buch T; Prazeres da Costa O; Esposito I; Burdach S; Richter GH
    Cancer Res; 2013 Jan; 73(2):967-77. PubMed ID: 23204234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.
    von Heyking K; Calzada-Wack J; Göllner S; Neff F; Schmidt O; Hensel T; Schirmer D; Fasan A; Esposito I; Müller-Tidow C; Sorensen PH; Burdach S; Richter GHS
    Mol Oncol; 2017 Sep; 11(9):1288-1301. PubMed ID: 28319320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
    Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM
    Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-124 represses the mesenchymal features and suppresses metastasis in Ewing sarcoma.
    Li Y; Shao G; Zhang M; Zhu F; Zhao B; He C; Zhang Z
    Oncotarget; 2017 Feb; 8(6):10274-10286. PubMed ID: 28055964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway.
    Lagares-Tena L; García-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Huertas-Martínez J; Sáinz-Jaspeado M; Mateo-Lozano S; Rodríguez-Galindo C; Rello-Varona S; Herrero-Martín D; Tirado OM
    Oncotarget; 2016 Aug; 7(35):56889-56903. PubMed ID: 27487136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.
    Satterfield L; Shuck R; Kurenbekova L; Allen-Rhoades W; Edwards D; Huang S; Rajapakshe K; Coarfa C; Donehower LA; Yustein JT
    Int J Cancer; 2017 Nov; 141(10):2062-2075. PubMed ID: 28748534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M is a growth factor for Ewing sarcoma.
    David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
    Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors.
    Grunewald TG; Diebold I; Esposito I; Plehm S; Hauer K; Thiel U; da Silva-Buttkus P; Neff F; Unland R; Müller-Tidow C; Zobywalski C; Lohrig K; Lewandrowski U; Sickmann A; Prazeres da Costa O; Görlach A; Cossarizza A; Butt E; Richter GH; Burdach S
    Mol Cancer Res; 2012 Jan; 10(1):52-65. PubMed ID: 22080479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
    Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
    Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis.
    Luo W; Xu C; Ayello J; Dela Cruz F; Rosenblum JM; Lessnick SL; Cairo MS
    Oncogene; 2018 Feb; 37(6):798-809. PubMed ID: 29059150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the gene regulatory program induced by the homeobox transcription factor distal-less 3 in mouse placenta.
    Han L; Dias Figueiredo M; Berghorn KA; Iwata TN; Clark-Campbell PA; Welsh IC; Wang W; O'brien TP; Lin DM; Roberson MS
    Endocrinology; 2007 Mar; 148(3):1246-54. PubMed ID: 17110422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth.
    Grunewald TG; Willier S; Janik D; Unland R; Reiss C; Prazeres da Costa O; Buch T; Dirksen U; Richter GH; Neff F; Burdach S; Butt E
    Biol Cell; 2013 Nov; 105(11):535-47. PubMed ID: 24033704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome profiling of Ewing sarcomas - treatment resistance pathways and IGF-dependency.
    Chen Y; Hesla AC; Lin Y; Ghaderi M; Liu M; Yang C; Zhang Y; Tsagkozis P; Larsson O; Haglund F
    Mol Oncol; 2020 May; 14(5):1101-1117. PubMed ID: 32115849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
    Kinsey M; Smith R; Lessnick SL
    Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.
    Nanni P; Nicoletti G; Landuzzi L; Croci S; Murgo A; Palladini A; Antognoli A; Ianzano ML; Stivani V; Grosso V; Maira SM; García-Echeverría C; Scotlandi K; De Giovanni C; Lollini PL
    Eur J Cancer; 2010 Feb; 46(3):659-68. PubMed ID: 20031388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERBB4 confers metastatic capacity in Ewing sarcoma.
    Mendoza-Naranjo A; El-Naggar A; Wai DH; Mistry P; Lazic N; Ayala FR; da Cunha IW; Rodriguez-Viciana P; Cheng H; Tavares Guerreiro Fregnani JH; Reynolds P; Arceci RJ; Nicholson A; Triche TJ; Soares FA; Flanagan AM; Wang YZ; Strauss SJ; Sorensen PH
    EMBO Mol Med; 2013 Jul; 5(7):1087-102. PubMed ID: 23681745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP6 Confers Sensitivity to IFN-Mediated Apoptosis through Modulation of TRAIL Signaling in Ewing Sarcoma.
    Henrich IC; Young R; Quick L; Oliveira AM; Chou MM
    Mol Cancer Res; 2018 Dec; 16(12):1834-1843. PubMed ID: 30131449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.